Latest1 information on COVID-19
©2022 Stanford Medicine
Magnesium Sulfate vs Placebo for Placental Abruption
Not Recruiting
Trial ID: NCT00186069
Purpose
To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.
Official Title
Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption
Stanford Investigator(s)
Yasser El-Sayed, Professor
Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery
Eligibility
Inclusion Criteria:
- vaginal bleeding and contractions consistent with suspected placental abruption between
24 and 34 weeks gestation.
Exclusion Criteria:
- preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy,
fetal distress
Intervention(s):
drug: Magnesium Sulfate
other: Normal Saline
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Iris Colon, MD
(408) 855-5550